• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人高胆固醇血症:解决治疗困境

Hypercholesterolemia in elderly persons: resolving the treatment dilemma.

作者信息

Denke M A, Grundy S M

机构信息

University of Texas Southwestern Medical Center, Dallas.

出版信息

Ann Intern Med. 1990 May 15;112(10):780-92. doi: 10.7326/0003-4819-112-10-780.

DOI:10.7326/0003-4819-112-10-780
PMID:2184712
Abstract

Of all age groups, men and women over 60 years of age have the highest prevalence of elevated serum cholesterol levels. Now that detection and treatment of high serum cholesterol levels are increasing, we need a rational approach to managing elevated cholesterol levels in elderly patients. Recent data indicate that high total cholesterol and low-density lipoprotein levels predict risk for coronary heart disease in patients over 60 years of age. However, selecting appropriate candidates for cholesterol-lowering therapy requires clinical judgment of the relative risks and benefits of each therapy and consideration of each patient's overall health status as well as of competing risks. Active medical management of high cholesterol levels, therefore, should be restricted to a limited fraction of elderly patients who are most likely to benefit from long-term therapy. The first line of treatment is diet modification; however, drug therapy for appropriate patients is not contraindicated because of age alone.

摘要

在所有年龄组中,60岁以上的男性和女性血清胆固醇水平升高的患病率最高。鉴于高血清胆固醇水平的检测和治疗正在增加,我们需要一种合理的方法来管理老年患者升高的胆固醇水平。最近的数据表明,高总胆固醇和低密度脂蛋白水平可预测60岁以上患者患冠心病的风险。然而,选择合适的降胆固醇治疗候选人需要对每种治疗的相对风险和益处进行临床判断,并考虑每个患者的整体健康状况以及竞争风险。因此,高胆固醇水平的积极医学管理应仅限于最有可能从长期治疗中受益的一小部分老年患者。一线治疗是饮食调整;然而,对于合适的患者,药物治疗并不因年龄本身而被禁忌。

相似文献

1
Hypercholesterolemia in elderly persons: resolving the treatment dilemma.老年人高胆固醇血症:解决治疗困境
Ann Intern Med. 1990 May 15;112(10):780-92. doi: 10.7326/0003-4819-112-10-780.
2
Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program.
Arch Intern Med. 1999;159(15):1670-8. doi: 10.1001/archinte.159.15.1670.
3
Is it advantageous to lower cholesterol in the elderly hypertensive?降低老年高血压患者的胆固醇是否有益?
Cardiovasc Drugs Ther. 2000 Aug;14(4):397-405. doi: 10.1023/a:1007812232328.
4
Management of older adults with hypercholesterolaemia.老年高胆固醇血症患者的管理
Drugs Aging. 1994 May;4(5):366-78. doi: 10.2165/00002512-199404050-00002.
5
Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?高胆固醇血症。降脂对老年患者是否值得?
Geriatrics. 2000 May;55(5):22-8.
6
Asessing coronary heart disease risk and managing lipids.评估冠心病风险与管理血脂。 (注:原英文文本中“Asessing”拼写错误,正确应为“Assessing” )
Nurse Pract. 2001 Dec;26(12):30-2, 34, 37-41; quiz 42-3. doi: 10.1097/00006205-200112000-00005.
7
Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.心脏移植后降胆固醇治疗:一项为期12个月的随机试验。
J Heart Lung Transplant. 1995 Jul-Aug;14(4):613-22.
8
Therapeutic intervention for hypercholesterolemia.
Clin Cardiol. 1992 Nov;15(11 Suppl 3):III18-21; discussion III22-4.
9
Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention.
Clin Pharm. 1988 Aug;7(8):592-603.
10
Hypercholesterolaemia in the elderly: is drug treatment justified?老年人高胆固醇血症:药物治疗是否合理?
Eur Heart J. 1988 Mar;9 Suppl D:79-82. doi: 10.1093/eurheartj/9.suppl_d.79.

引用本文的文献

1
Statin Therapy in Very Old Patients: Lights and Shadows.老年患者的他汀类药物治疗:光明与阴影
Front Cardiovasc Med. 2021 Nov 29;8:779044. doi: 10.3389/fcvm.2021.779044. eCollection 2021.
2
No association between elevated homocysteine levels and carotid atherosclerosis in a rural population in China.在中国农村人群中,同型半胱氨酸水平升高与颈动脉粥样硬化之间不存在关联。
Stroke Vasc Neurol. 2016 Dec 19;1(4):154-160. doi: 10.1136/svn-2016-000037. eCollection 2016 Dec.
3
Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men.
实现最佳风险因素水平以预防老年男性心血管疾病的主要益处。
J Clin Lipidol. 2012 Jan-Feb;6(1):58-65. doi: 10.1016/j.jacl.2011.10.019. Epub 2011 Nov 7.
4
Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study.确立心血管踝指数作为动脉硬化新指标的基线标准:一项横断面研究。
BMC Cardiovasc Disord. 2011 Aug 10;11:51. doi: 10.1186/1471-2261-11-51.
5
Comprehensive Geriatric Assessment in the Office: Uncovering all the problems of geriatric patients.在办公室进行综合老年评估:发现老年患者的所有问题。
Can Fam Physician. 1991 Oct;37:2187-94.
6
Variability in the prescription of cardiovascular medications in older patients: correlates and potential explanations.老年患者心血管药物处方的变异性:相关性和潜在解释。
Drugs Aging. 2009 Dec;26 Suppl 1:41-51. doi: 10.2165/11534650-000000000-00000.
7
Lipid-lowering therapy for the primary prevention of cardiovascular disease in the elderly: opportunities and challenges.降脂治疗在老年人心血管疾病一级预防中的作用:机遇与挑战。
Drugs Aging. 2009;26(11):917-31. doi: 10.2165/11318270-000000000-00000.
8
The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention.老年患者用药证据不断增加的影响。第1部分。用于一级和二级心血管预防的他汀类药物。
Br J Clin Pharmacol. 2006 May;61(5):494-501. doi: 10.1111/j.1365-2125.2006.02609.x.
9
Management strategies of dyslipidemia in the elderly: 2005.老年人血脂异常的管理策略:2005年
MedGenMed. 2005 Oct 10;7(4):8.
10
Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.急性心肌梗死老年患者中羟甲基戊二酰辅酶A还原酶抑制剂:年龄与他汀类药物相互作用的证据
J Am Geriatr Soc. 2006 Mar;54(3):421-30. doi: 10.1111/j.1532-5415.2005.00635.x.